Your browser doesn't support javascript.
loading
Impact of Initial Imaging Protocol on Likelihood of Endovascular Stroke Therapy.
Lopez-Rivera, Victor; Abdelkhaleq, Rania; Yamal, Jose-Miguel; Singh, Noopur; Savitz, Sean I; Czap, Alexandra L; Alderazi, Yazan; Chen, Peng R; Grotta, James C; Blackburn, Spiros; Spiegel, Gary; Dannenbaum, Mark J; Wu, Tzu-Ching; Yoo, Albert J; McCullough, Louise D; Sheth, Sunil A.
Affiliation
  • Lopez-Rivera V; Department of Neurology (V.L.-R., R.A., S.I.S., A.L.C., Y.A., G.S., T.-C.W., L.D.M., S.A.S.).
  • Abdelkhaleq R; Department of Neurology (V.L.-R., R.A., S.I.S., A.L.C., Y.A., G.S., T.-C.W., L.D.M., S.A.S.).
  • Yamal JM; School of Public Health (J.-M.Y., N.S.), UTHealth, Houston, TX.
  • Singh N; Institute for Stroke and Cerebrovascular Disease (J.-M.Y., S.I.S., A.L.C., Y.A., P.R.C., J.C.G., S.B., S.A.S.), UTHealth, Houston, TX.
  • Savitz SI; School of Public Health (J.-M.Y., N.S.), UTHealth, Houston, TX.
  • Czap AL; Department of Neurology (V.L.-R., R.A., S.I.S., A.L.C., Y.A., G.S., T.-C.W., L.D.M., S.A.S.).
  • Alderazi Y; Institute for Stroke and Cerebrovascular Disease (J.-M.Y., S.I.S., A.L.C., Y.A., P.R.C., J.C.G., S.B., S.A.S.), UTHealth, Houston, TX.
  • Chen PR; Department of Neurology (V.L.-R., R.A., S.I.S., A.L.C., Y.A., G.S., T.-C.W., L.D.M., S.A.S.).
  • Grotta JC; Institute for Stroke and Cerebrovascular Disease (J.-M.Y., S.I.S., A.L.C., Y.A., P.R.C., J.C.G., S.B., S.A.S.), UTHealth, Houston, TX.
  • Blackburn S; Institute for Stroke and Cerebrovascular Disease (J.-M.Y., S.I.S., A.L.C., Y.A., P.R.C., J.C.G., S.B., S.A.S.), UTHealth, Houston, TX.
  • Spiegel G; Department of Neurosurgery of McGovern Medical School (P.R.C., S.B., M.J.D.), UTHealth, Houston, TX.
  • Dannenbaum MJ; Institute for Stroke and Cerebrovascular Disease (J.-M.Y., S.I.S., A.L.C., Y.A., P.R.C., J.C.G., S.B., S.A.S.), UTHealth, Houston, TX.
  • Wu TC; Institute for Stroke and Cerebrovascular Disease (J.-M.Y., S.I.S., A.L.C., Y.A., P.R.C., J.C.G., S.B., S.A.S.), UTHealth, Houston, TX.
  • Yoo AJ; Clinical Innovation and Research Institute, Memorial Hermann Hospital, Texas Medical Center, Houston (J.C.G.).
  • McCullough LD; Department of Neurosurgery of McGovern Medical School (P.R.C., S.B., M.J.D.), UTHealth, Houston, TX.
  • Sheth SA; Institute for Stroke and Cerebrovascular Disease (J.-M.Y., S.I.S., A.L.C., Y.A., P.R.C., J.C.G., S.B., S.A.S.), UTHealth, Houston, TX.
Stroke ; 51(10): 3055-3063, 2020 10.
Article in En | MEDLINE | ID: mdl-32878563

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain / Brain Ischemia / Tissue Plasminogen Activator / Stroke / Fibrinolytic Agents Type of study: Guideline / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Stroke Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain / Brain Ischemia / Tissue Plasminogen Activator / Stroke / Fibrinolytic Agents Type of study: Guideline / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Stroke Year: 2020 Document type: Article